Peter Sonsini Insider Profile
4 Followers
Peter Sonsini, Ten Percent Owner at IonQ, holds 4.75M shares in Arcellx Inc (Ticker: ACLX), holds 0.00 shares in AKOUOS (Ticker: AKUS), holds 14.62M shares in IonQ (Ticker: IONQ).
Peter Sonsini's Trading History
| ACLXArcellx Inc | Dec 22, 2022 | ― | Uninformative Sell | ― | $546.13M | |
| AKUSAKOUOS | Dec 02, 2022 | ― | Uninformative Sell | ― | $0.00 | |
| IONQIonQ | Nov 18, 2022 | Ten Percent Owner | Uninformative Sell | ― | $476.89M | |
| AVEOAVEO Pharma | Oct 21, 2022 | ― | Uninformative Sell | ― | $24.34K | |
| GNCAQGenocea Biosciences | May 26, 2022 | ― | Informative Sell | 711.52K | ― | |
| HOODRobinhood | May 04, 2022 | Director | Uninformative Sell | ― | $1.93B | |
| TRVITrevi Therapeutics | Apr 13, 2022 | Ten Percent Owner | Informative Buy | 6.80M | $162.94M | |
| MTCRMetacrine | Dec 27, 2021 | ― | Informative Sell | 493.91K | $1.49M | |
| GLUEMonte Rosa Therapeutics | Jun 30, 2021 | Ten Percent Owner | Uninformative Buy | ― | $81.31M | |
| NEUENeueHealth Inc | Jun 30, 2021 | ― | Uninformative Buy | ― | $1.23B | |
| EAREargo | May 26, 2021 | ― | Uninformative Sell | ― | $11.62M | |
| MRSNMersana Therapeutics | Sep 16, 2020 | ― | Uninformative Buy | ― | $173.34M | |
| INZYInozyme Pharma | Jul 28, 2020 | ― | Uninformative Buy | ― | $9.75M | |
| NKTXNkarta | Jul 16, 2020 | Ten Percent Owner | Uninformative Buy | ― | $5.02M | |
| ADAPYAdaptimmune Therapeutics | Jan 28, 2020 | Ten Percent Owner | Informative Buy | 4.95M | $1.95M | |
| ARDXArdelyx | Dec 09, 2019 | Ten Percent Owner | Uninformative Buy | 2.50M | $18.91M | |
| MIRMMirum Pharmaceuticals | Jul 24, 2019 | Ten Percent Owner | Uninformative Buy | ― | $392.33M | |
| RGLSRegulus | May 09, 2019 | ― | Informative Buy | 1.23M | $16.75M | |
| MULEMulesoft Inc | May 09, 2018 | ― | Uninformative Sell | ― | $0.00 | |
| SURFSurface Oncology | Apr 23, 2018 | ― | Uninformative Buy | ― | $3.54M | |
| TCONTRACON Pharmaceuticals | Mar 27, 2018 | ― | Informative Buy | 1.91M | $110.91K | |
| CASCCascadian Therapeutics | Mar 13, 2018 | ― | Uninformative Sell | ― | $0.00 | |
| ORKAOruka Therapeutics | Feb 27, 2018 | Ten Percent Owner | Informative Sell | 730.10K | $0.00 | |
| APPNAppian | Feb 15, 2018 | Ten Percent Owner | Uninformative Buy | ― | $52.37K | |
| SYBXSynlogic | Jan 26, 2018 | Ten Percent Owner | Uninformative Buy | 4.00M | $4.65M | |
| AKAOQAchaogen | Dec 19, 2016 | ― | Informative Buy | 6.75M | $117.88K | |
| LOXOLoxo Oncology | Aug 06, 2014 | ― | Uninformative Buy | ― | $419.91M |
You May Also Like
Peter Sonsini insider profile FAQ
What is the percentage of profitable transactions made by Peter Sonsini?
The percentage of profitable transactions made by Peter Sonsini is 20%.
What is the average return per transaction made by Peter Sonsini?
The average return per transaction made by Peter Sonsini is -19.70%.
What stocks does Peter Sonsini hold?
Peter Sonsini holds: IONQ, ORKA, AVEO, CASC, RGLS, GNCAQ, AKAOQ, ADAPY, SYBX, MULE, APPN, MRSN, SURF, TRVI, MIRM, AKUS, NKTX, INZY, MTCR, EAR, NEUE, GLUE, HOOD, ACLX, ARDX, TCON, LOXO stocks.
What was Peter Sonsini's most profitable transaction?
Peter Sonsini’s most profitable transaction was an Informative Buy of AKAOQ stock on June 7, 2016. The return on the trade was 423.70%.
What is Peter Sonsini's role in IonQ?
Peter Sonsini's role in IonQ is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
